BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1811199)

  • 1. The long-term stability of reconstituted exametazime: a clinical and laboratory evaluation.
    Hawkins T; Reeder A; Keavey PM; Thakker S; Hawker R
    Nucl Med Commun; 1991 Dec; 12(12):1045-55. PubMed ID: 1811199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99Tcm-exametazime-labelled leucocytes: effect of volume and concentration of exametazime on labelling efficiency, and clinical protocol for high efficiency multi-dose radiolabelling.
    Sampson CB; Solanki C; Barber RW
    Nucl Med Commun; 1991 Aug; 12(8):719-23. PubMed ID: 1780111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A routine method for using sodium iodide to stabilize sodium pertechnetate [99Tcm] dispensed for the preparation of 99Tcm-exametazime.
    Millar AM
    Nucl Med Commun; 1992 May; 13(5):306-11. PubMed ID: 1318530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
    Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
    Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime.
    Danpure HJ; Osman S; Carroll MJ
    Nucl Med Commun; 1988 Jun; 9(6):465-75. PubMed ID: 3412734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
    Tsai CS; Kao CH; Yeh SJ; Wang SJ
    Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pertechnetate source and age on the radiochemical purity of technetium Tc 99m exametazime.
    Ponto JA
    Am J Hosp Pharm; 1990 Nov; 47(11):2511-3. PubMed ID: 2177584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
    Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
    Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of white blood cell labelling with 99Tcm radiopharmaceuticals.
    Segall GM; Lang EV; Chaovapong W
    Nucl Med Commun; 1994 Oct; 15(10):845-9. PubMed ID: 7838449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99Tcm-phenylene imine phenol as a potential leukocyte labelling agent.
    Huang WT; Lo JM; Kao CH; Wang SJ
    Nucl Med Commun; 1997 Jan; 18(1):66-9. PubMed ID: 9061704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization and multidose use of exametazime for cerebral perfusion studies.
    Solanki C; Li DJ; Wong A; Barber RW; Wraight EP; Sampson CB
    Nucl Med Commun; 1994 Sep; 15(9):718-22. PubMed ID: 7816385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.
    Ecclestone M; Proulx A; Ballinger JR; Gerson B; Reid RH; Gulenchyn KY
    Eur J Nucl Med; 1990; 16(4-6):299-302. PubMed ID: 2161770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime.
    Millar AM
    Am J Hosp Pharm; 1993 Jan; 50(1):103-6. PubMed ID: 8381258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-labelled autologous lymphocytes: clinical protocol for radiolabelling using a high concentration and low volume of 99Tcm-exametazime.
    Sampson CB; Goffin E
    Nucl Med Commun; 1991 Oct; 12(10):875-8. PubMed ID: 1792022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiochemical purity testing for 99Tcm-exametazime: a comparison study for three-paper chromatography.
    Hung JC; Taggart TR; Wilson ME; Owens TP
    Nucl Med Commun; 1994 Jul; 15(7):569-74. PubMed ID: 7970436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for stabilising technetium-99m exametazime prepared from a commercial kit.
    Weisner PS; Bower GR; Dollimore LA; Forster AM; Higley B; Storey AE
    Eur J Nucl Med; 1993 Aug; 20(8):661-6. PubMed ID: 8404951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labelling of leucocytes with technetium-99m exametazime causes in vitro upregulation of granulocyte CD11b without correlation to tissue uptake in vivo.
    Almer S; Ljunghusen O; Lundahl J
    Eur J Nucl Med; 1996 Jun; 23(6):669-74. PubMed ID: 8662101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid method for the preparation of 99Tcm hexametazime-labelled leucocytes.
    Solanki KK; Mather SJ; Janabi MA; Britton KE
    Nucl Med Commun; 1988 Oct; 9(10):753-61. PubMed ID: 3211434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99Tcm-HMPAO leucocyte scintigraphy in the diagnosis of bone infection.
    Moragas M; Lomeña F; Herranz R; García A; Piera C; Muxí A; Bassa P; Catafau A; Pavía A; Setoain J
    Nucl Med Commun; 1991 May; 12(5):417-27. PubMed ID: 2067746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.